US NIH lacked COVID-19 home treatment guidelines for two years, leading patients to seek alternatives like the McCullough Protocol. Gulick et al. acknowledged lessons learned but overlooked ivermectin's efficacy, which many found effective. NIH's advising against ivermectin hindered frontline doctors. Overall, agencies seem to have not learned from the pandemic experience.
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned Review of Failed Government Recommendations Reveals Most Doctors and Citizens Wanted Ivermectin Wed, 09 Oct 2024 09:09:56 GMT https://petermcculloughmd.substack.com/p/national-institutes-of-health-covid By Peter A. McCullough, MD, MPH
The US National Institutes of Health did not have recommendations for sick patients with acute COVID-19 at home to help them avoid hospitalization or death until December 2021 when Paxlovid was FDA EUA authorized.
That means for for two years during the most serious phases of the pandemic, the US government guidelines did not meet the needs of the public. People were desperate to avoid the hospital and it is no wonder they sought and utilized the McCullough Protocol which featured a range of choices in a step by step method.
Roy M. Gulick, Alice K. Pau, Eric Daar, et al. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned . Ann Intern Med. [Epub 1 October 2024]. doi:10.7326/ANNALS-24-00464
Gulick et al, published a “lessons learned” paper in Annals of Internal Medicine and missed the point on the interest in ivermectin which exceeded all other drugs. Doctors and patients were finding success with ivermectin in combination with other nutraceuticals and drugs and could not believe our government would not test it in such a combination in a large (>20,000 per arm), multicenter, randomized trial. To make matters worse, the NIH guidelines advised against using ivermectin, which impeded doctors on the front line who found it effective and a part of community standard of care.
It appears as if our agencies have learned no lessons thus far in the pandemic. We will need much more time before capitulation.
Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
Roy M. Gulick, Alice K. Pau, Eric Daar, et al. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. Ann Intern Med. [Epub 1 October 2024]. doi:10.7326/ANNALS-24-00464